The original patent submission was filed by US Cellular Dynamics International (CDI), now a subsidiary of Fujifilm, and claims the production of induced pluripotent stem cells from a small amount of peripheral blood using an episomal vector. The claims overlap to some extent with claims of CiRA, Kyoto University.

Fujifilm news release, October 19, 2016